ResMed Deferred revenue, net of current portion increased by 2.1% to $163.15M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $151.09M to $163.15M. Over 4 years (FY 2021 to FY 2025), Deferred revenue, net of current portion shows an upward trend with a 14.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals strong long-term contract growth and future revenue stability, while a decrease may indicate slowing long-term bookings.
This represents revenue that has been billed or collected from customers for services to be delivered beyond the next tw...
Common in SaaS and subscription-based service models; peers in the HCM and payroll space report this to show contract duration.
non_current_liabilities_contract_with_customer_liability_a5d23a| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $91.50M | $93.26M | $94.43M | $94.09M | $95.46M | $97.62M | $102.80M | $108.88M | $119.19M | $121.49M | $127.41M | $131.98M | $137.34M | $144.45M | $146.51M | $151.09M | $156.80M | $159.36M | $159.79M | $163.15M |
| QoQ Change | — | +1.9% | +1.3% | -0.4% | +1.4% | +2.3% | +5.3% | +5.9% | +9.5% | +1.9% | +4.9% | +3.6% | +4.1% | +5.2% | +1.4% | +3.1% | +3.8% | +1.6% | +0.3% | +2.1% |
| YoY Change | — | — | — | — | +4.3% | +4.7% | +8.9% | +15.7% | +24.9% | +24.5% | +23.9% | +21.2% | +15.2% | +18.9% | +15.0% | +14.5% | +14.2% | +10.3% | +9.1% | +8.0% |